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Daughter of Sevenless Is a Substrate
of the Phosphotyrosine Phosphatase Corkscrew
and Functions during Sevenless Signaling
Ronald Herbst,*² Pamela M. Carroll,*² exchange factor Son of sevenless (SOS), with the auto-
phosphorylated receptor. Translocation of the GRB2±John D. Allard,² James Schilling,³ Thomas Raabe,§
SOS complex from the cytosol to the plasma membraneand Michael A. Simon²
results in an enhanced level of activated GTP bound²Department of Biological Sciences
RAS. Activated RAS, in turn, initiates a phosphorylationStanford University
cascade consisting of the serine/threonine kinases RAF,Stanford, California 94305-5020
MEK, and MAPK (Avruch et al., 1994). Activated MAPK³Sugen, Inc.
can then modulate the activity of various transcription515 Galveston Road
factors.Redwood City, California 94063
An extensively studied example of RTK mediated sig-§Theodor Boveri Institut fuer Biowissenschaften
nal transduction is the role of the RTK encoded by theLehrstuhl Genetik
sevenless gene during Drosophila compound eye devel-Universitaet Wuerzburg
opment (Zipursky and Rubin, 1994). The sole function97074 Wuerzburg
of the sevenless RTK (SEV) is to trigger neuronal differen-Federal Republic of Germany
tiation in the single R7 cell within each ommatidium of
the eye in response to the presentation of its ligand,
Bride of sevenless (BOSS), on the surface of the neigh-Summary
boring R8 photoreceptor cell.Using genetic screens and
epistasis experiments, many components of the signalThe SH2 domain±containing phosphotyrosine phos-
transduction pathway initiated in the R7 precursor cellphatase Corkscrew (CSW) is an essential component
by the activation of SEV have been identified. Theseof the signaling pathway initiated by the activation of
include DRK (the Drosophila GRB2 homolog; Simon etthe sevenless receptor tyrosine kinase (SEV) during
al., 1993; Olivier et al., 1993), SOS (Simon et al., 1991;Drosophila eye development. We have used genetic
Bonfini et al., 1992), RAS1 (Simon et al., 1991), RAF
and biochemical approaches to identify a substrate
(Dickson et al., 1992), MEK (Tsuda et al., 1993; Hsu and
for CSW. Expression of a catalytically inactive CSW
Perrimon, 1994), and MAPK (Brunner et al., 1994b; Biggs
was used to trap CSW in a complex with a 115 kDa et al., 1994).
tyrosine-phosphorylated substrate. This substrate An unresolved question about signal transduction
was purified and identified as the product of the
within the R7 cell is whether all the effects of SEV activa-
daughter of sevenless (dos) gene. Mutations of dos
tion are mediated through the activation of RAS1 by
were identified in a screen for dominant mutations DRK and SOS. Our previous studies have suggested
which enhance the phenotype caused by overexpres- the existence of a second signaling pathway whose
sion of inactive CSW during photoreceptor develop- function is required during SEV signaling (Allard et al.,
ment. Analysis of dos mutations indicates that DOS is 1996). We identified dominantly inhibiting and constitu-
a positive component of the SEV signaling pathway tively signaling forms of corkscrew (CSW), a phosphoty-
and suggests that DOS dephosphorylation by CSW rosine phosphatase (PTP) that contains two amino-ter-
may be a key event during signaling by SEV. minal SH2 domains (Perkins et al., 1992). Previous
studies have implicated CSW as an essential component
of the signaling pathway initiated by the torso RTK (Per-
Introduction kins et al., 1992). We used these dominant corkscrew
alleles to perform genetic epistasis experiments with
Receptor tyrosine kinases (RTKs) play important roles activated and inhibiting forms of RAS1. The results indi-
in the regulation of cell growth and differentiation. The cated that efficient signaling by RAS1 and CSW are each
binding of a specific ligand to the extracellular domain dependent on the presence of the activity of the other.
of an RTK leads to receptor dimerization, activation of This suggested that CSW might act in a pathway that
was parallel to the RAS1 pathway.the cytoplasmic kinase domain, and autophosphoryla-
In this report, we have investigated the CSW signalingtion on tyrosine residues (Schlessinger and Ullrich,
pathway by searching for substrates of the phosphatase1992). The activated receptor then initiates intracellular
activity of CSW. We describe the identification of a 115signaling pathways by interacting with specific cellular
kDa protein that is a CSW substrate and may also be atargets (Cantley et al., 1991). Frequently, these targets
direct or indirect target for the tyrosine kinase activitycontain one or more SRC homology 2 (SH2) domains,
of SEV. We show that this protein is encoded by thewhich mediate their interactions with phosphorylated
daughter of sevenless gene (dos; Raabe et al., 1996 [thistyrosine residues of RTKs (Pawson, 1995). One crucial
issue of Cell]) and that mutations which inactivate dosconsequence of RTK activation is stimulation of RAS
dominantly enhance the effects of reduced CSW activitysignaling activity (Egan and Weinberg, 1993). This stimu-
and suppress the effects of either excessive SEV orlation depends on interaction of a complex, consisting of
CSW activity. These results indicate that DOS is a crucialthe adaptor molecule GRB2 and the guanine nucleotide
component of the SEV signaling pathway and strongly
suggest that dephosphorylation of DOS by CSW pro-




A 115 kDa Protein Is a Target of the PTP
Activity of CSW
Our approach to understanding the role of CSW during
SEV signaling was to identify physiological substrates
of the phosphatase activity of CSW. The biochemical
approach that we used was modeled after experiments
which showed that a catalytically inactive mutant form
of the MKP-1 phosphatase forms stable complexes in
vivo with its substrates, phosphorylated p42mapk and
p44mapk (Sun et al., 1993). We constructed an equivalently
mutated form of csw, cswC583S, and expressed the re-
sulting protein (CSWCS) in Drosophila SL2 cells under
the control of the Actin5C promoter (Simon et al., 1989).
The resulting cell line (SL2±CSWCS) was examined for
tyrosine-phosphorylated proteins that could be copre-
cipitated with CSWCS using anti-CSW antisera. A 115
kDa phosphotyrosine-containing protein (p115) was
specifically detected in CSW immunoprecipitates from
lysates of SL2±CSWCS cells but was barely detectable
in anti-CSW immunoprecipitates of either untransfected
SL2 cells or SL2 cells that overexpressed wild-type csw
(SL2±CSW; Figure 1A). Antiphosphotyrosine immu-
noblotting of whole cell extracts from SL2±CSWCS cells
further indicated that p115 was one of the major tyro-
sine-phosphorylated proteins present in SL2±CSWCS
cells but was not a major phosphotyrosine-containing
protein in SL2 or SL2±CSW cells (Figure 1B).
The most likely explanation for these results is that
p115 is phosphorylated normally by endogenous ki-
nases present in SL2 cells, but that SL2 cells contain
active CSW, and perhaps other PTPs, which rapidly de- Figure 1. Interaction of CSW with a 115 kDa Tyrosine Phosphory-
lated Protein (p115)phosphorylate p115. The expression of CSWCS would
The upper panel of (A) is an antiphosphotyrosine immunoblot ofthen permit the accumulation of phosphorylated p115
anti-CSW immunoprecipitates. The cell line used to prepare theby binding to and protecting p115 from the action of
extract is indicated above each lane. The lower panel of (A) is anthe endogenous CSW. A prediction of this model is that
anti-CSW immunoblot of the identical anti-CSW immunoprecipitateswild-type CSW must be capable both of forming a
shown in the upper panel. Abundant CSW expression is seen in the
complex with phosphorylated p115 and of dephosphor- SL2±CSW and SL2±CSWCS lines. While not apparent in this expo-
ylating p115. We tested each of these predictions. In sure, SL2 cells also express a detectable amount of CSW.
order to demonstrate that phosphorylated p115 and (B) shows an antiphosphotyrosine immunoblot of total cell extracts
from these same cell lines. The position of the tyrosine-phosphory-wild-type CSW can associate in vivo, we examined
lated p115 protein that coprecipitates with CSWCS is indicated.whether phosphorylated p115 could be coprecipitated
(C) shows an antiphosphotyrosine immunoblot of anti-CSW immu-with wild-type CSW from normal SL2 cells which had
noprecipitates from SL2 cells that were treated with the PTP inhibitorbeen treated with the membrane-permeable PTP inhibi-
pervanadate for 5 min prior to lysis. Similar results were obtained
tor pervanadate (Fantus et al., 1989; Heffetz et al., 1990). when SL2±CSWCS cells were treated with pervanadate. The positions
This treatment results in a rapid increase in the overall and molecular masses (kDa) of marker proteins are indicated to the
level of protein±tyrosine phosphorylation within the cells left of each panel.
(data not shown). Tyrosine-phosphorylated p115 was
readily detectable in anti-CSW immunoprecipitates from
CSW and possibly other PTPs are prevented from cata-either SL2 or SL2±CSWCS cells after treatment with per-
lyzing the dephosphorylation of p115.vanadate (Figure 1C). With increasing concentrations of
In order to demonstrate that CSW could use phos-the PTP inhibitor, the signal obtained in antiphospho-
phorylated p115 as a substrate, tyrosine-phosphory-tyrosine immunoblots was enhanced several-fold, and
lated p115 was isolated from pervanadate-treated SL2the p115 band showed decreased electrophoretic mo-
cells by coprecipitation with anti-CSW antiserum. A puri-bility, suggesting that p115 might be phosphorylated
fied bacterially expressed fusion protein (GST±CAT) thaton multiple tyrosine residues under these conditions.
consisted of the CSW catalytic domain fused to glutathi-Treatment with pervanadate also resulted in phosphory-
one S-transferase (GST) was then added to the immuno-lation of CSW on tyrosine residues. In addition to p115,
precipitate, and the dephosphorylation of p115 wastwo other tyrosine-phosphorylated proteins with molec-
monitored by antiphosphotyrosine immunoblotting afterular masses of 170 kDa (p170) and 190 kDa (p190), re-
SDS±polyacrylamide gel electrophoresis (SDS±PAGE).spectively, could be coprecipitated both with CSW and
The addition of GST±CAT resulted in the rapid dephos-CSWCS. These results show that wild-type CSW can in-
teract stably with phosphorylated p115, provided that phorylation of p115 (Figure 2). In contrast, the addition
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Figure 2. A Fusion Protein Containing the Catalytic Domain of CSW,
GST±CAT, Can Dephosphorylate Tyrosine Phosphorylated p115
Figure 3. The SH2 Domains of CSW Are Crucial for Interacting with
SL2 cells were treated with pervanadate, lysed, and then immuno- Tyrosine-Phosphorylated p115
precipitated with anti-CSW antiserum. The washed precipitates
(A) shows an antiphosphotyrosine immunoblot of whole cell ex-were then incubated with either no added protein, GST, GST fused
tracts. The cell line used to prepare the extract is indicated aboveto the catalytic domain of CSW, or GST fused to an inactive CSW
each lane.catalytic domain containing the cswC583S mutation. Dephosphoryla-
(B) Binding of p115 to the CSW SH2 domains. In order to removetion of p115 was monitored by antiphosphotyrosine immunoblot.
excess CSWCS that was not bound to p115, the CSWCS/p115 complexThe positions of CSW and the p190, p170, and p115 proteins that
was partially purified from SL2±CSWCS cells by ion-exchange chro-precipitate with CSW from pervanadate-treated cells are indicated.
matography. The column eluate was subjected to precipitation with
either anti-CSW antiserum, antiphosphotyrosine antibodies, GST
bound to glutathione±agarose beads, or GST±SH2SH2 bound to
of GST alone or a GST±CATprotein containing the inacti- glutathione±agarose beads. The presence of p115 was detected by
vating cswC583S substitution (GST±CATCS) had no effect antiphosphotyrosine immunoblot. Despite the presence of numer-
on the phosphotyrosine content of p115. These results ous phosphotyrosine-containing proteins in the sample, only p115
could be precipitated by the SH2 domains of CSW.indicate that CSW can dephosphorylate p115 in vitro
and support the proposal that phosphorylated p115 is
a direct target for CSW dephosphorylation. Tyrosine-
phosphorylated p170 and p190 were also rapidly de- phosphorylated p115 was confirmed by demonstrating
phosphorylated by the addition of GST±CAT, indicating that an immobilized fusion protein containing GST and
that these proteins might also be possible substrates the SH2 domains of CSW (GST±SH2SH2) was able to
of CSW. precipitate phosphorylated p115 from extracts of SL2±
CSWCS cells. In order to generate conditions in which
The Interaction Between p115 and CSWCS GST±SH2SH2 could effectively compete with CSWCS for
Depends on the SH2 Domains of CSW binding to phosphorylated p115, the bulk of free CSWCS
The presence of phosphorylated tyrosine residues on was removed from the extracts of SL2±CSWCS cells by
p115 suggested that the association of CSW and p115 anion exchange chromatography. After removal of free
might involve interactions between phosphorylated CSWCS, GST±SH2SH2 was able effectively to precipitate
p115 and one or both of the SH2 domains of CSW. In phosphorylated p115 (Figure 3B). Despite the presence
order to address this issue, we established an SL2 cell of many tyrosine-phosphorylated proteins in the eluate,
line, which stably expressed CSWCS, that contained p115 was the only tyrosine-phosphorylated protein that
inactivating mutations in both of the SH2 domains bound to GST±SH2SH2, indicating the high degree of
(CSWSH2*SH2*CS). Residues arginine-32 and arginine-137 specificity in the interaction of tyrosine-phosphorylated
were exchanged for lysine residues. These residues are p115 and the SH2 domains of CSW. These results con-
part of the highly conserved FLVRES motif and cor- firm that the SH2 domains of CSW play an important
respond to arginine-175 of c-src, a residue which is cri- role in p115 recognition.
tical for interaction of the SH2 domain with tyrosine-
phosphorylated ligands (Pawson, 1995). Lysates of this
cell line were analyzed for the presence of tyrosine- p115 Is Tyrosine-Phosphorylated in Response
to Constitutively Active SEVphosphorylated p115 (Figure 3A). The expression of
CSWSH2*SH2*CS was not sufficient to induce an accumula- Since SL2 cells do not express SEV, the tyrosine phos-
phorylation of p115 in SL2±CSWCS cells must be cata-tion of tyrosine-phosphorylated p115. These results
suggest that one or both of the SH2 domains of CSW lyzed by other kinases that are present in these cells.
However, the crucial role of CSW during SEV signalingare important for the interactionof CSW with phosphory-
lated p115. suggested that p115 might also be a substrate for SEV.
In order to examine the effect of SEV activity on p115The ability of the SH2 domains of CSW to interact with
Cell
902
phosphorylation of p115. Furthermore, the apparent
shift in mobility upon SEVS11 induction suggested that
at least some of the induced p115 phosphorylation oc-
curred at sites that were distinct from those sites which
were phosphorylated in SL2±CSWCS cells that did not
express SEV. As a control for the effects of heat shock
on p115 phosphorylation, we also examined the tyro-
sine phosphorylation and mobility of p115 from heat-
shocked SL2±CSWCS cells. In this case, no increase in
tyrosine-phosphate content was observed, though there
was a short-lived decrease in electrophoretic mobility
that might be due to other covalent modifications of
p115, such as serine/threonine phosphorylation.
These results suggest that p115 is either a direct or
indirect target for the kinase activity of SEV. One issue
that is raised by these results is whether p115 might
also be a target for phosphorylation in response to the
induction of other RTKs. Therefore, we examined the
effect on p115 phosphorylation of activation of the Dro-
sophila insulin receptor in response to mammalian insu-
lin (Fernandez et al., 1995). SL2 and SL2±CSWCS cells
were each starved for 24 hr in serum-free media and
then stimulated with increasing concentrations of insu-
lin. Antiphosphotyrosine immunoblot analysis revealed
a dose-dependent increase in tyrosine phosphorylation
of a 170 kDa protein that most likely represented the
insulin receptor according to its response to insulin and
Figure 4. Induction of SEV But Not Insulin Receptor Kinase Activity molecular mass (Figure 4B). Insulin stimulation had no
Leads to Increased Phosphorylation of p115
effect on the phosphorylation state of p115. This result
The upper portion of (A) shows an antiphosphotyrosine immunoblot
indicates that the ability of SEVS11 to induce tyrosineof extracts prepared from either SL2±CSWCS or SL2±CSWCS cells
phosphorylation of p115 is not a general property pos-that express SEVS11 under the control of a heat-shock responsive
sessed by all RTKs.promoter. Cells either were not heat shocked or were placed at
378Cfor 30 min and then allowed to recover for 2, 4, or 6 hr. The lower
panel of (A) shows an anti-SEV immunoblot of the same extracts that
shows the accumulation of the 58 kDa subunit of SEV. Induction of Purification of p115
SEV activity leads to an increase in the intensity of antiphosphotyro-
The evidence that p115 is both a substrate for dephos-sine staining of p115 and a shift of p115 to a larger apparent molecu-
phorylation by CSW and a target for either direct orlar mass. In contrast, heat-shock treatment of SL2±CSWCS cells
leads only to a much more transientchange in electrophoretic mobil- indirect phosphorylation by SEV indicated that p115
ity and no apparent change in the phosphotyrosine content of p115. might play a crucial role in signaling by SEV. We sought
(B) shows an antiphosphotyrosine immunoblot of extracts prepared to investigate this role both by identifying the gene that
from SL2±CSWCS cells that were serum-starved for 24 hr and then
encoded p115 and by studying mutations that inacti-treated with various concentrations of bovine insulin. The concen-
vated p115. In order to identify the p115 gene, we puri-tration of insulin (ng/ml) used is given above each lane. Addition of
fied sufficient p115 for microsequence analysis. The pu-insulin results in significant activation and phosphorylation of insulin
receptor without any observable change in the phosphorylation or rification scheme was based on the ability of CSWCS to
electrophoretic mobility of p115. bind phosphorylated p115 specifically and to prevent
dephosphorylation by cellular phosphatases including
CSW. Cytosolic extracts of SL2±CSWCS cells were pre-phosphorylation, we expressed a constitutively acti-
pared in the absence of PTP inhibitors and allowed tovated versionof SEV(SEVS11) under heat-shockpromoter
undergo dephosphorylation by endogenous PTPs for 50control in SL2 cells (SL2±SEVS11 cells) or in SL2 cells that
min at room temperature. During this period, virtuallyalso expressed CSWCS (SL2±CSWCSSEVS11 cells; Basler
all phosphotyrosine-containing proteins in the extractet al., 1991; Simon et al., 1993). Upon heat-shock induc-
were dephosphorylated, with the exception of p115. Fol-tion, SEVS11 is synthesized as a 90 kDa precursor, which
lowing this treatment, the extract was denatured by boil-is then cleaved to yield 58 and 48 kDa forms (Simon et
ing in an SDS-containing buffer, diluted to lower theal., 1991). While SEVS11 autophosphorylation could be
concentration of SDS, and then immunoprecipitatedreadily detected in SL2±SEVS11 cells, SEVS11 expression
with antiphosphotyrosine antibodies. This procedure re-did not result in other obvious changes in the spectrum
sulted in a preparation that contained a single majorof cellular tyrosine phosphorylation (data not shown). In
protein band that was 115 kDa in apparent molecularcontrast, induction of SEVS11 in cells expressing CSWCS
mass. We used this protocol to purify approximately 4led toan increase in the tyrosine-phosphate content and
mg of p115 from 4 3 109 SL2±CSWCS cells. The sequencea concurrent decrease in the electrophoretic mobility of
of a single tryptic peptide (XXMSVGNLYSQGXN) wasp115 (Figure 4A). Thus, the induction of SEV activity can
lead either directly or indirectly to enhanced tyrosine obtained.
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A Screen for Mutations Affecting CSW Function as dominant suppressors of the ability of a membrane-
At the same time that we sought to identify the gene targeted form of CSW (CSWsrc90) to induce R7 develop-
that encoded p115, we also sought to isolate mutant ment in the cone cell precursors (Figures 5D and 5H;
alleles of the gene encoding p115 and of other genes Allard et al., 1996). This result was consistent with the
that might encode components of the CSW portion of E(cswCS)3A product playing a crucial role downstream
the SEV signaling pathway. We began by examining the of CSW during R7 development. Finally, the phenotype
effects of expression of CSWCS in the developing eye. of clones of homozygous mutant E(cswCS)3A cells gener-
For this purpose, a P element, P[sevhs±cswCS], which ated in the eyes of heterozygous animals was identical
expressed CSWCS under the control of sevenless tran- to the clonal phenotype of cells lacking csw function
scriptional enhancer elements, was constructed and (Allard et al., 1996). In each case, homozygous mutant
transformed into flies. This P element directed expres- cells can proliferate but do not differentiate as photore-
sion of CSWCS in several cells of the developing eye ceptors (data not shown; Allard et al., 1996). These re-
disc, including the precursors to photoreceptors R3, sults indicate that the E(cswCS)3A product, like CSW, is
R4, and R7. Flies carrying P[sevhs±cswCS] had mildly required during the development of every photoreceptor
roughened eyes owing to the frequent absence of photo- of the developing ommatidium.
receptors R3, R4, and R7 from mature ommatidia (Fig- In order to understand more about where the E(cswCS)
ures 5A and 5B). This phenotype is the result of the 3A protein might act during SEV signaling, we examined
ability of CSWCS to inhibit the function of wild-type CSW, the effects of E(cswCS)3A mutations on signaling by acti-
which is required for neuronal differentiation in these vated SEV (SEVS11), RAS1 (RAS1V12), and RAF (RAFTOR)
cells (Allard et al., 1996). The inhibitory effect of CSWCS proteins expressed under the control of sevenless tran-
expression could be entirely reversed by the expression scriptional enhancers (Basler et al., 1991; Fortini et al.,
of wild-type CSW (data not shown). 1992; Dickson et al., 1992). The external eye morphology
We reasoned that if p115 was an important target of is a sensitive assay for limiting components of the signal-
CSW during photoreceptor development, then lowering ing pathway that are downstream of these activated
the amount of functional p115 present during photore- proteins, because expression of the activated proteins
ceptor development by inactivating one copy of the results in a dose-dependent eye roughness owing to
p115 gene might affect the severity of the phenotype the abnormal recruitment of cone cell precursors to the
induced by P[sevhs±cswCS]. However, since we did not R7 developmental fate (Dickson et al., 1995; Chang et al.,
know whether p115 might need to be dephosphorylated 1995; Therrien et al., 1995). Heterozygosity for E(cswCS)
to allow its active participation in signaling, or whether 3A suppressed the phenotype caused by SEVS11 but
dephosphorylation might instead prevent phosphory- had no effect on the phenotype caused by RAS1V12 or
lated p115 from blocking signaling, we could not predict RAFTOR (Figure 5). These results indicated that the level
whether p115 mutations would make theP[sevhs±cswCS] of E(cswCS)3A function was limiting during signaling by
phenotype more or less severe. We therefore mutagen- activated SEV, but not during signaling by either acti-
ized flies and screened for mutations that acted either as vated RAS1 or RAF. These data are consistent with
dominant enhancers or suppressors of P[sevhs±cswCS]. placement of the E(cswCS)3A protein on a part of the
The complete results of the mutagenesis screen will SEV signaling pathway that is either before RAS1/RAF
be published elsewhere. In summary, approximately activation or ina pathway that is parallel to the activation
75,000 progeny of ethylmethylsulfonate-treated flies
of RAS1 and RAF.
were screened. Mutations were identified which af-
fected several genes that were already known to encode
important components of the SEV signaling pathway. E(cswCS)3A Is dos and Encodes p115
Suppressors of P[sevhs±cswCS] included activated al-
The E(cswCS)3A locus was meiotically mapped to the
leles of Sos. Inactivating alleles of sos, Ras1, and
62E±F region of the Drosophila chromosomes. We then
pointed were identified as enhancers of the P[sevhs±
became aware that a screenconducted in the laboratorycswCS] phenotype (Simon et al., 1991; O'Neill et al., 1994;
of E. Hafen, for mutations that dominantly suppress theBrunner et al., 1994a).
SEVS11 phenotype, had identified a gene, dos, that re-The screen for mutations that modify the P[sevhs±
sided in this same region of the chromosome (Raabe etcswCS] phenotypealso identifiedseveral additionalgenes
al., 1996). Since both dos and E(cswCS)3A mutationsthat have not been previously described. We chose to
are lethal when homozygous, we tested for allelism byfocus on one of the novel loci, E(cswCS)3A, for several
asking whether E(cswCS)3A and dos mutations comple-reasons. First, we isolated seven alleles of E(cswCS)3A.
mented each other for viability. The mutations failed toThis high frequency indicated that these alleles were
complement, indicating that E(cswCS)3A is dos.likely to result from inactivation of the E(cswCS)3A gene
Raabe et al. (1996) had already isolated the dos generatherthan fromthe creation of a novel function. Second,
and determined its sequence. Conceptual translation oftheeffect of E(cswCS)3A mutationson theP[sevhs±cswCS]
the dos cDNA predicts a protein of 97 kDa that has littlephenotype (Figures 5C and 5D) was stronger than the
homology to known proteins except for the presence ofeffects of mutations in any of the other novel comple-
a pleckstrin homology domain (see Raabe et al., 1996,mentation groups that we identified. Since our data sug-
for a full discussion of the dos sequence; Gibson et al.,gested that p115 was the direct target for CSW action,
1994). However, immunoblotting with antibodies to DOSwe expected that mutations in the p115 gene would
indicates that DOS migrates as a 115 kDa protein inhave a profound effect on the P[sevhs±cswCS] pheno-
type. Third, E(cswCS)3A mutations are capable of acting SDS±PAGE (T. R. and E. Hafen, unpublished data). We
Cell
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Figure 5. Genetic Analyis of E(cswCS)3A Mutations
(A) shows a scanning electron micrograph (SEM) of a phenotypically wild-type eye of a w1118 fly. The eye is smooth in appearance and has
the normal regular array of photoreceptors. This can be seen in apical tangential sections of w1118 flies (E). The pattern of seven photoreceptors
can be seen by observing the darkly staining structures that are the rhabdomeres (light-sensing organelles) of each photoreceptor. The
presence of R7 cells can be scored by the presence of the R7 rhabdomere, which is smaller and more centrally located than the rhabdomeres
of R1±R6.
(B) shows an SEM of an eye of a heterozygous P[sevhs±cswCS] fly. The surface of the eye is roughened owing to abnormalities in the structure
of the underlying ommatidia (F), including the frequent absence of R7 and one or two of the R1±R6 class photoreceptors. Examination of the
neuronal development of these eyes indicates that R3 and R4 are most frequently absent (data not shown).
(C) shows an SEM of a fly that is heterozygous both for P[sevhs±cswCS] and for E(cswCS)3A1.46. The presence of the E(cswCS)3A1.46 mutation
enhances the eye roughness of flies carrying P[sevhs±cswCS] and leads to more severe abnormalities in the photoreceptor content of individual
ommatidia (G). Flies heterozygous for the E(cswCS)3A mutations alone have no detectable defects in eye morphology or ommatidial structure
(data not shown).
(D) shows an apical tangential section of P[sevhs±cswsrc90] flies. Many ommatidia have extra R7 photoreceptors owing to enhanced signaling
by the membrane-targeted CSWsrc90 protein.
(H) The dominant effect of enhanced signaling by CSWsrc90 is suppressed by the E(cswCS)3A2.42 mutation. The average number of R7-like cells
per ommatidium is reduced from 2.15 to 1.4 by the presence of the E(cswCS)3A2.42 mutation. This result suggests that the E(cswCS)3A protein
is a limiting component during CSWsrc90 signaling.
(I) and (J) show SEMs of flies heterozygous for P[sevRas1V12]2 or both P[sevRas1V12]2 and E(cswCS)3A1.46, respectively (Fortini et al., 1992). The
presence of the E(cswCS)3A mutation has no apparent effect on the signaling ability of RAS1V12. Similar results were obtained with flies
expressing the activated RAFTor protein instead of RAS1V12 (data not shown).
(K) and (L) show SEMs of flies hemizygous for P[SE±SevS11] (K) or hemizygous for P[SE±SevS11] and heterozygous for E(cswCS)3A1.46 (L). In
contrast to signaling by RAS1V12, the effectiveness of signaling by SEVS11 was attenuated by the presence of the E(cswCS)3A1.46 mutation,
indicating that the E(cswCS)3A protein is a limiting component during SEVS11 signaling. Similar results for all these experiments were obtained
with several alleles of E(cswCS)3A.
therefore directly tested whether dos encoded p115 by noblot analysis, both of anti-CSW immunoprecipitates
from SL2±CSWCS cells and of purified p115 preparationssearching for the p115 peptide sequence (XXMSV
GNLYSQGXN) in DOS. A match was found in the pre- (Figure 6). These results clearly show that the tyrosine-
phosphorylated p115 protein that coprecipitated withdicted DOS tryptic fragment SSMSVGNLYSQGGN-
GASGMR (amino acids 816±835). This indicated that dos CSWCS and the protein that we purified for micro-
sequence analysis are recognized by anti-DOS anti-encoded the p115 substrate of CSW. In order to validate
this conclusion further, we performed anti-DOS immu- bodies.
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the formation of a complex between CSWCS and phos-
photyrosine-containing protein, DOS. Several lines of
biochemical evidence suggest that DOS is a genuine
substrate for CSW. First, previous studies of other PTPs
in which the equivalent cysteine residue has been mu-
tated to serine suggest that this mutation creates a cata-
lytic domain that is inactive but that retains the ability
to bind substrate with high affinity (Sun et al., 1993;
Milarski et al., 1993; Guan and Dixon, 1991). Second,
the addition of a fusion protein containing a catalytically
active domain of CSW to extracts containing tyrosine-
phosphorylated DOS leads to the rapid dephosphoryla-
tion of DOS. Finally, the ability of the CSWCS proteinFigure 6. The Tyrosine-Phosphorylated p115 Protein Is Recognized
to protect DOS from dephosphorylation by other PTPsby Anti-DOS Antibodies
during our DOS purification protocol suggests that di-Cytosolic extracts were prepared from the cell line indicated above
each lane. These extracts were then either precipitated with anti- rect contacts are made between the catalytic domain
CSW antiserum and subjected to SDS±PAGE (anti-CSW), or else of CSW and the phosphorylated tyrosine residues of
first allowed to undergo dephosphorylation by endogenous PTPs DOS. In addition, the ability of DOS mutations to act
and then denatured and precipitated with antiphosphotyrosine anti-
as genetic modifiers of the CSWCS rough-eye phenotypebodies and subjected to SDS±PAGE (anti-PY). The procedure used
is entirely consistent with DOS being a direct targetto generate the protein samples in the anti-PY precipitates is equiva-
of CSW.lent to that used to generate p115 for microsequencing and yields
a major 115 kDa band from SL2±CSWCS cells but not from either SL2
or SL2±CSW cells. The right panel shows an antiphosphotyrosine
immunoblot of these samples and shows that tyrosine-phosphory- Models for CSW and DOS Function During
lated p115 is present at high levels in the anti-CSW and anti-PY SEV Signaling
samples from SL2±CSWCS cells but not from equivalent samples of
Our isolation of dos mutations as dominant enhancerseither SL2 or SL2±CSW cells. The left panel shows an anti-DOS
of the phenotypic effects of inadequate CSW functionimmunoblot of the same precipitates and of unprecipitated extracts
implies that DOS cooperates with CSW during SEV sig-(Total). Analysis of the unprecipitated extracts shows that DOS is
present in extracts of all three cell lines and that DOS migrates as naling. When combined with the ability of DOS to act
a 115 kDa protein during SDS±PAGE. Analysis of the anti-CSW as a substrate for the PTP activity of CSW, this genetic
samples indicates that DOS coprecipitates with CSWCS but not with information suggests possible roles for CSW and DOS
wild-type CSW produced in either SL2 or SL2±CSW cells. Similarly,
during SEV signaling. We propose that prior to SEV acti-DOS is found in the anti-PY precipitates of SL2±CSWCS cells but not
vation, DOS phosphorylation at specific tyrosine resi-in those derived from either SL2 or SL2±CSW cells.
dues is maintained by the action of a presently unidenti-
fied kinase. The activation of SEV by BOSS then leads
to activation of the PTP activity of CSW and the subse-Discussion
quent dephosphorylation of DOS by CSW. Dephosphor-
ylated DOS would then be free to participate actively inDuring Drosophila ommatidial development, effective
signaling by the SEV RTK is essential for the precursors the initiation of R7 photoreceptor development. Proof
of this model for CSW and DOS function will requireof R7 photoreceptor cells to differentiate as neurons.
Previous studies have provided evidence for the possi- identification of the particular phosphotyrosine residues
of DOS which are targets for dephosphorylation byble existence of two signaling pathways that are crucial
for signaling by SEV. The better characterized pathway CSW. This model predicts that mutations which reduce
the phosphorylation of these specific tyrosines mightis initiated by recruitment of the SOS±DRK signaling
complex to the activated and autophosphorylated SEV generate overly active DOS.
Since the only recognizable feature of the predicted(Zipursky and Rubin, 1994). This recruitment step leads
to the activation of RAS1 and the stimulation of a MAPK DOS peptide sequence is the presence of a pleckstrin
homology domain, we presently can only speculate onpathway that is very similar to those that have been
characterized in vertebrate cells. The less characterized the precise role of DOS function after dephosphorylation
by CSW during SEV signaling (Raabe et al., 1996). Thepathway involves the action of the SH2 domain±
containing PTP CSW. Our previous genetic studies of ability of DOS mutations to act as dominant suppressors
of the phenotype caused by expression of an activateddominant csw alleles have indicated that CSW function
is essential for SEV action and have further suggested SEV but not the same phenotype when induced by acti-
vated RAS1 or RAF expression suggests two possiblethat at least a portion of CSW function is either down-
stream of RAS1 activation or else in a pathway that acts placements of DOS action in the SEV signaling pathway.
The simplest model is that the sole important functionin parallel to the RAS1/RAF pathway (Allard et al., 1996).
In this study, we have further characterized the action of DOS is to contribute to RAS1 activation (Figure 7A).
DOS mutations would thus fail to act as heterozygousof CSW during SEV signaling by identifying a substrate
for the PTP activity of CSW. suppressors of RAS1V12 signaling because the RAS1V12
protein would already be fully activated. The secondIn our biochemical search for CSW substrates, we
employed a catalytically inactive CSW, CSWCS, to trap possibility is that DOS functions in a pathway that nor-
mally acts in conjunction with RAS1 duringSEV signalinga substrate in a complex with CSW. We found that over-
expression of CSWCS in Drosophila SL2 cells resulted in (Figure 7B). This model postulates that SEV normally
Cell
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that this model does not exclude the possibility that
DOS and CSW also contribute to RAS1 activation. Each
of these models is entirely consistent with presently
available genetic data. Support for the first model comes
from several studies of CSW and its mammalian homo-
log, SH±PTP2, which have suggested that the level of
CSW function can affect RAS1 and MAPK activation (Lu
et al., 1993; Li et al., 1994; Bennett et al., 1994; Milarski
and Saltiel, 1994; Noguchi et al., 1994; Tang et al., 1995;
Zhao et al., 1995). Support for the second model comes
both from numerous biochemical studies of vertebrate
RTK signaling which have demonstrated that RTKs stim-
ulate multiple signaling pathways and from our previous
genetic experiments, which have shown that CSW func-
tion during R7 development cannot be placed geneti-
cally solely upstream of RAS1 activation (Allard et al.,
1996). A fuller understanding of the role of DOS and
CSW will require elucidation of the activity of DOS and
the targets of DOS action.
These models are each consistent with all of our pres-
ent data, but both leave many issues unresolved. One
important question is the identity and possible regula-
tion of the kinase that maintains DOS in a phosphory-
lated state prior to the activation of SEV. Since this
phosphorylation is proposed to maintain DOS in an inac-
tive state, we predict that mutations which decrease
the activity of this kinase might be expected to act as
suppressors of the phenotype caused by CSWCS expres-
sion. Several new suppressor loci were found in our
genetic screen for CSWCS modifiers, but the products
of these genes have not yet been characterized.
Another critical issue raised by our proposed models
is how CSW activity might be regulated by SEV. It is
important to note that none of our present genetic data
demands that the level of CSW activity change during
SEV signaling. Another possibility is that CSW maintains
DOS in its dephosphorylated state at all times. Our data
suggest that this may be the case in SL2 cells, because
phosphorylation of DOS is only detectable in the pres-
ence of CSWCS. Nevertheless, regulation of CSW by SEV
is an attractive proposal, because RTK induced activa-
tion of the mammalian homolog of CSW, SH±PTP2, has
been previously reported (Vogel et al., 1993; Lechleider
et al., 1993). SH±PTP2 activation appears tobe mediated
by binding of the SH2 domains of SH±PTP2 to specific
Figure 7. Two Models for the Action of DOS during R7 Differenti- phosphorylated tyrosines of the activated RTK (Vogel
ation
et al., 1993; Feng et al., 1993; Lechleider et al., 1993).
Only the phosphorylated tyrosine residue or residues of DOS which In some cases, phosphorylation of SH±PTP2 by the acti-
are a substrate for dephosphorylation by CSW are indicated. Other
vated RTK also occurs and may contribute to the en-tyrosine residues which may be sites for phosphorylation by SEV
hancement of SH±PTP2 activity (Vogel et al., 1993; Fengare not shown. See Discussion for details.
et al., 1993; Lechleider et al., 1993). This model for PTP
activation is unlikely to apply to the interaction of CSW
directs R7 development by combining a moderate level with SEV. While we have detected coimmunoprecipita-
of RAS1 activation with the stimulation of other positive tion of CSW and SEV, this interaction is dependent nei-
signaling molecules such as DOS and CSW, but that ther on SEV phosphorylation nor on functional SH2 do-
overexpression of mutationally activated RAS1 or RAF mains of CSW (unpublished data). Furthermore, SEV
activates the MAPK cascade so strongly that activation appears to be unable to induce CSW phosphorylation
of the other branches of the SEV signaling pathway is in SL2 cells. Instead, our results suggest that the primary
no longer required. Under these conditions, the reduc- function of the SH2 domains of CSW during SEV signal-
tion of function of the CSW±DOS signaling branch ing may be the recognition of DOS.
caused by the inactivation of only one allele of DOS The role of DOS phosphorylation by SEV is another
might have little effect on signaling. Thus, DOS muta- important issue that will require further study. Our cur-
tions would fail to act as dominant suppressors of the rent results indicate that SEV activation can lead to en-
hanced DOS phosphorylation in cultured Drosophilaactivated RAS1 and RAF phenotypes. It is worth noting
DOS Is a Corkscrew Substrate during R7 Development
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Protein Analysiscells, but we do not have any direct evidence for SEV
Immunoblotting and immunoprecipitation were prepared as previ-phosphorylation of DOS in the R7 precursor cell during
ously described (Herbst et al., 1995). The following antibodies wereSEV signaling. Several roles for this putative phosphory-
used: PY20, a monoclonal antibody against phosphotyrosine (Trans-
lation of DOS by SEV seem possible. DOS phosphoryla- duction Laboratories); monoclonal antibody 78C10, which recog-
tion by SEV could act to enhance the ability of the SH2 nizes the catalytic domain of SEV; CT-1, a rat polyclonal antiserum
raised against a GST±fusion protein containing the carboxy-terminaldomains of CSW to bind to DOS and thus be a mecha-
159 amino acids of CSW; CT-1±2, a polyclonal rabbit antiserumnism by which SEV stimulates CSW to dephosphorylate
raised against a GST±fusion protein containing the carboxy-terminalkey phosphotyrosines of DOS. Alternatively, phosphory-
610 amino acids, and affinity purified with the antigen used to raiselation of DOS by SEV could stimulate a presently un-
CT-1. The serum CT-1 was used for all immunoprecipitations of
knowncatalytic activity of DOS. Finally, phosphorylation CSW, whileCT-1±2 was used for immunoblotting. Anti-DOSantibod-
of DOS might allow DOS to bind to other signaling mole- ies are described by Raabe et al. (1996). The GST expression vectors
used were either pGEX (Guan and Dixon, 1991) or pGEX-2TK (Phar-cules in a manner similar to IRS-1 and GAB-1 (Myers
macia).and Morris, 1993; Hogado-Madruga et al., 1996). Inter-
For in vitro dephosphorylation experiments, the catalytic domainestingly, each of these proteins shares with DOS the
of CSW (residues 231±681) was expressed as a GST±fusion proteinproperty of having an amino-terminal pleckstrin homol-
(GST±CAT). SL2 cells were incubated with 200 mM pervanadate for
ogy domain (Gibson et al., 1994). 15 min at room temperature, lysed in lysis buffer without phospha-
tase inhibitors, and immunoprecipitated (107 cell equivalents) with
antiserum CT-1. The precipitates were first washed twice with wash-Conservation with Other RTK Signaling Pathways
ing buffer (without phosphatase inhibitors) and then once in phos-Since signaling pathways of Drosophila and mammalian
phatase buffer (100 mM MES [pH 6.8], 150 mM NaCl, 5 mM DTT,RTKs are highly conserved, it is likely that a vertebrate
and 2 mM EDTA). Dephosphorylation reactions were done by resus-
homolog of p115 existswhich is a substrate of SH±PTP2. pending the precipitates in 50 ml of phosphatase buffer containing
Two potential SH±PTP2 substrates that are approxi- 3 mg of GST±fusion proteins and incubating for 30 min at room
mately the same size as DOS have been described. A temperature. The reactions were stopped by the addition of SDS
sample buffer.115 kDa phosphotyrosine protein could be coprecipi-
Ion exchange chromatography of CSW±DOS was performed astated with either wild-type or catalytically inactive SH±
follows. Extracts from SL2±CSWCS cells were prepared by threePTP2 from insulin-treated cells (Yamauchi et al., 1995).
freeze/thaw cycles in buffer A (20 mM Tris [pH 7.5], 10% glycerol,
This protein has several properties that are distinct from 2 mM orthovanadate, 10 mM NaF, 2 mM sodium pyrophosphate)
DOS. For example, this p115 could not be precipitated containing 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin,
by the SH2 domains of SH±PTP2 and was tyrosine- and 10 mg/ml leupeptin, cleared by centrifugation at 12,500 3 g for
20 min at 48C, diluted with an equal volume of buffer A/200 mMphosphorylated in response to insulin treatment. An-
NaCl, and loaded on a High-Q anion exchange column (BioRad).otherstudy detected a 120 kDatyrosine-phosphorylated
The column was washed with buffer A/100 mM NaCl and boundprotein whose properties are similar to the Drosophila
proteins eluted with buffer A/200 mM NaCl. For precipitations with
p115 (Milarski and Saltiel, 1994). The 120 kDa protein GST±SH2SH2 (amino acids 1±218 of CSW), the eluate was adjusted
was only tyrosine-phosphorylated in cells expressing an to 150 mM NaCl and 0.5% Triton X-100 and mixed with glutathione
inactive SH±PTP2 and could be precipitated by the SH2 beads to which GST±SH2SH2 was bound.
For purification of DOS, SL2±CSWCS cells (4 3 109) were harvesteddomains of SH±PTP2. Determining if one or more of
by centrifugation, lysed in 20 ml of lysis buffer lacking phosphatasethese proteins is homologous to DOS will require the
inhibitors, incubated at room temperature for 50 min, and then cen-cloning of their respective cDNAs. An interesting possi-
trifuged at 45,000 3 g for 30 min at 48C. The supernatant was then
bility is that both CSW and SH±PTP2 may each have a precleared by incubation with agarose cross-linked to monoclonal
number of different substrates in different types of cells antibody PY20 for 1 hr at 48C, adjusted to 1% SDS, and heated to
and in response to the activation of different RTKs. 908C for 5 min. The lysate was then diluted with 9 vol of immunopre-
cipitation washing buffer containing 0.3% Triton X-100 and loaded
on an anti-phosphotyrosine (PY20) column. The columnwas washedExperimental Procedures
with immunoprecipitation washing buffer, and tyrosine-phosphory-
lated proteins were eluted in washing buffer containing 50 mMDrosophila Culture and Histology
p-nitrophenylphosphate (Sigma). The eluate was concentrated inFly culture, crosses,mutagenesis, and germlinetransformation were
a Centricon concentrator (Amicon), subjected to SDS±PAGE, andperformed using standard procedures. Mutagenized males from an
transferred onto nitrocellulose. A single protein of 115 kDa couldisogenic stock were crossed to females of the genotype TM3,
be stained on the membrane with amidoblack. The band was ex-P[sevhs±cswcs]/TM6b. F1 progeny were scored for modifications
cised from the membrane and used for microsequencing.in the rough-eye phenotype caused by the expression of CSWcs.
Histological analysis of flies was as previously described (Simon et
al., 1991). The Drosophila Schneider cell line 2 (SL2) was maintained Acknowledgments
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